octamethyl pyrophosphoramide and Myasthenia Gravis

octamethyl pyrophosphoramide has been researched along with Myasthenia Gravis in 7 studies

*Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. [MeSH]

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
MILLER, DH; WILLIAMS, JP; WILSON, CW	1
FUTCH, ED; GREGORY, L; STONE, CT	1
RICHTER, RB; RIDER, JA; SCHULMAN, S	1
RICHTER, RB; RIDER, A; SCHULMAN, S	1
KAPLAN, LI; OSSERMAN, KE	1
DUBOIS, KP; MOELLER, HC; RICHTER, RB; RIDER, JA; SCHULMAN, S	1
DUBOIS, KP; MOELLER, HC; RICHTER, R; RIDER, JA; SCHULMAN, S	1

Other Studies

7 other study(ies) available for octamethyl pyrophosphoramide and Myasthenia Gravis

Article	Year
The hazard of cholinergic crisis during treatment of myasthenia gravis with octamethyl pyrophosphoramide. Annals of internal medicine, 1952, Volume: 37, Issue:3 Topics: Atropine; Cholinergic Agents; Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds	1952
Octamethyl pyrophosphoramide in the therapy of myasthenia gravis. The American journal of medicine, 1952, Volume: 13, Issue:4 Topics: Diphosphates; Myasthenia Gravis; Organophosphorus Compounds	1952
Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations. A.M.A. archives of neurology and psychiatry, 1953, Volume: 69, Issue:5 Topics: Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds	1953
Use of octamethyl pyrophosphoramide in the treatment of myasthenia gravis; further observations. Journal of the American Medical Association, 1953, Aug-29, Volume: 152, Issue:18 Topics: Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds	1953
Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA). Annals of internal medicine, 1954, Volume: 41, Issue:1 Topics: Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds	1954
Treatment of myasthenia gravis with octamethyl pyrophosphoramide; preliminary report. Journal of the American Medical Association, 1951, Mar-31, Volume: 145, Issue:13 Topics: Diphosphates; Myasthenia Gravis; Organophosphorus Compounds	1951
Treatment of myasthenia gravis with octamethyl pyrophosphoramide (peptox III): a preliminary report. A.M.A. archives of neurology and psychiatry, 1951, Volume: 66, Issue:2 Topics: Humans; Myasthenia Gravis; Organophosphorus Compounds	1951